GGrantIndex
Sort

25,944 grants matching neurodegeneration

New Mechanisms of Mitochondrial Toxicity: Focus on Antibacterial Agent Cetylpyridinium Chloride Effects on Immune and Barrier Cells

$526,441
Julie Ann Gosse · University Of Maine Orono · R15 · FY2025 · ES

Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology

$526,392
Maria F Braga · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2011 · NS

Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus

$526,392
Laxmikant S Deshpande · Virginia Commonwealth University · UG3 · FY2024 · NS

Development of an Agonist of the TGF-beta Signaling Pathway to Treat Alzheimer's

$526,363
Tony Wyss-Coray · Palo Alto Veterans Instit For Research · U01 · FY2008 · NS

Neurophysiological Aspects of Vision-based Speed of Processing Cognitive Training in Older Adults with Mild Cognitive Impairment

$526,294
Feng Vankee Lin · University Of Rochester · R01 · FY2016 · NR

Using Technology to Support Care Partners for Persons with Alzheimer's Disease: Tele-STELLA

$526,210
Allison Lindauer · Oregon Health & Science University · R56 · FY2020 · AG

TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis

$526,207
Joanna L Jankowsky · Baylor College Of Medicine · P01 · FY2023 · AG

TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis

$526,207
Joanna L Jankowsky · Baylor College Of Medicine · P01 · FY2021 · AG

TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis

$526,204
Joanna L Jankowsky · Baylor College Of Medicine · P01 · FY2024 · AG

Multidisciplinary Research Fellowship in Alzheimer's disease and Related Dementias

$526,199
Howard J Rosen · University Of California, San Francisco · T32 · FY2022 · AG

Novel Pathways of HAARTmediated Neuronal Toxicity in the Central Nervous System

$526,062
Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2009 · MH

Molecular imaging of brain injury and repair in NFL players

$526,060
Jennifer Marie Coughlin · Johns Hopkins University · R01 · FY2018 · NS

NEURODEGENERNATION RESEARCH PROGRAM (NRP)

$526,031
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2010 · RR

Determining the role of CLN3 in the eye

$525,938
Ruchira Singh · University Of Rochester · R01 · FY2019 · EY

Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease

$525,712
Jagdish Singh · North Dakota State University · R01 · FY2024 · AG

Molecular basis of lysosomal dysfunction in Alzheimer's disease and approaches to therapeutic remediation

$525,606
Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2020 · AG

Essential Function of miR-29 in the Mature Brain

$525,602
Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AG

Essential Function of miR-29 in the Mature Brain

$525,602
Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AG

Plasticity in the Aging Olfactory System

$525,595
John W Cave · Winifred Masterson Burke Med Res Inst · R01 · FY2015 · DC

TRACKING NEURODEGENERATION IN EARLY WOLFRAM SYNDROME

$525,520
Tamara G Hershey · Washington University · R01 · FY2014 · HD

Novel Approaches for in vivo of mGluRs

$525,392
Massachusetts General Hospital · R01 · FY2004 · EB

Regulation and recognition of eat-me signals in the nervous system

$525,313
Chun Han · Cornell University · R01 · FY2025 · NS

Effects of TDP-43 Proteinopathy on Retrotransposon Activation and Cell-Type Specific Vulnerability in a Mammalian Model of Alzheimer's and Related Dementias

$525,293
Roger B Sher · State University New York Stony Brook · R01 · FY2025 · AG

ROS driven mitochondrial-telomere dysfunction during environmental stress

$525,233
Bennett Van Houten · University Of Pittsburgh At Pittsburgh · R33 · FY2018 · ES

Genetic etiology of Amyotrophic Lateral Sclerosis

$525,138
Bryan Traynor · National Institute On Aging · ZIA · FY2025 · AG